The latest closing stock price for Quince Therapeutics as of November 20, 2024 is 1.84.
An investor who bought $1,000 worth of Quince Therapeutics stock at the IPO in 2019 would have $-944 today, roughly -1 times their original investment - a -38.16% compound annual growth rate over 6 years.
The all-time high Quince Therapeutics stock closing price was 120.21 on August 10, 2021.
The Quince Therapeutics 52-week high stock price is 2.14, which is 16.3% above the current share price.
The Quince Therapeutics 52-week low stock price is 0.51, which is 72.3% below the current share price.
The average Quince Therapeutics stock price for the last 52 weeks is 0.99.
An investor who bought $1,000 worth of Quince Therapeutics stock at the IPO in 2019 would have $-944 today, roughly -1 times their original investment - a -38.16% compound annual growth rate over 6 years.
The all-time high Quince Therapeutics stock closing price was 120.21 on August 10, 2021.
The Quince Therapeutics 52-week high stock price is 2.14, which is 16.3% above the current share price.
The Quince Therapeutics 52-week low stock price is 0.51, which is 72.3% below the current share price.
The average Quince Therapeutics stock price for the last 52 weeks is 0.99.